Article History
Received: 24 January 2023
Accepted: 5 February 2023
First Online: 17 February 2023
Disclosures
: Ravit Geva: honoraria (self) from Roche, MSD, Merck, Medison, Janssen, Pfizer, and BMS. Advisory/consultancy in AstraZeneca (7/2022), BOL Pharma (ended 3/2022), Roche, Ranium, JNJ, Bayer, and MSD (6/2022). Leadership roles in Pyxis, and medical lead. Shareholder/stockholder/stock options in Pyxis (options). Travel/accommodations/expenses: Takeda (1/2022) and Medison (6/2022).